Patent ID: 8802726

Claim:
A method of treating muscular dystrophies comprising administering to a subject a nitric oxide releasing compound of formula (Ia) M-X—Y—ONO 2 (Ia) or enantiomers or diastereoisomers thereof, wherein in the general formula (Ia), M, X and Y have the following meanings: M is a residue X is —O—, —S— or —NR 1 —, wherein R 1 is H or linear or branched C 1 -C 6 alkyl; Y is a bivalent radical having the following meanings: straight or branched C 1 -C 20 alkylene being optionally substituted with one or more of the substituents selected from the group consisting of: halogen atoms, hydroxy, —ONO 2 and T, wherein T is —OC(O)(C 1 -C 10 alkyl)-ONO 2 or —O(C 1 -C 10 alkyl)-ONO 2 ; or —C 5 -C 7 cycloalkylene group optionally substituted with linear or branched C 1 -C 10 alkyl group.